What is the current Adults Genetic Disease Diagnosis market size?

The Adults Genetic Disease Diagnosis market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Adults Genetic Disease Diagnosis market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by advances in genetic testing.

What are the key drivers of the Adults Genetic Disease Diagnosis market?

Key drivers include increasing demand for genetic testing and growing awareness of genetic diseases among adults.

What are the major challenges facing the Adults Genetic Disease Diagnosis market?

Challenges include high costs of genetic testing and limited reimbursement options for patients.

Which regions are leading the Adults Genetic Disease Diagnosis market?

North America and Europe are currently the leading regions, due to high adoption rates of genetic testing.

Who are the top companies in the Adults Genetic Disease Diagnosis market?

Top companies include Illumina, Thermo Fisher Scientific, and Quest Diagnostics, offering a range of genetic testing services.

What future opportunities exist in the Adults Genetic Disease Diagnosis market?

Future opportunities include the development of new genetic testing technologies and expansion into emerging markets.

How is technology impacting the Adults Genetic Disease Diagnosis market?

Advances in next-generation sequencing and artificial intelligence are improving the accuracy and speed of genetic testing.

What is the current regulatory landscape for the Adults Genetic Disease Diagnosis market?

The regulatory landscape is evolving, with increasing focus on ensuring the safety and efficacy of genetic testing products.

What is the future outlook for the Adults Genetic Disease Diagnosis market?

The future outlook is positive, with growing demand for genetic testing and increasing adoption of precision medicine approaches.

Adults Genetic Disease Diagnosis - 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

Adults Genetic Disease Diagnosis by Application (Hospital, Medical Laboratory, Others), by Types (Prenatal Diagnosis, Screening for Single Gene Genetic Disease, Preimplantation Genetic Testing, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 87

Forecast Period: 2026 - 2033

Market Size: $7800 million

CAGR: 16.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 87

Forecast Period: 2026 - 2033

Market Size: $7800 million

CAGR: 16.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Adults Genetic Disease Diagnosis Market Size | CAGR 16.2 Forecast 2033

Adults Genetic Disease Diagnosis - 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

🏭 Healthcare🌍 Global

Pages: 87

Forecast Period: 2026 - 2033

Market Size: $7800 million

CAGR: 16.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 87

Forecast Period: 2026 - 2033

Market Size: $7800 million

CAGR: 16.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Adults Genetic Disease Diagnosis Market Overview

The Adults Genetic Disease Diagnosis market refers to the industry that provides diagnostic solutions for genetic disorders in adults. As the Adults Genetic Disease Diagnosis market size is projected to reach $8.3 billion by 2026, the growth outlook and market forecast indicate a significant expansion in the industry. The industry expansion is driven by increasing demand for genetic testing and diagnosis, and the market is expected to grow at a CAGR of 7.5% during the forecast period from 2026 to 2033. The scope of the market includes genetic testing, genetic counseling, and genetic diagnosis for adults, with a focus on precision medicine and personalized healthcare.

Loading chart…

The key forces shaping the industry include technology shifts towards next-generation sequencing, regulations supporting genetic testing, and consumer behavior driving demand for personalized healthcare. The largest region in the Adults Genetic Disease Diagnosis market is North America, while the fastest-growing region is Asia-Pacific. The market is expected to be driven by increasing awareness of genetic diseases, advancements in genetic testing technologies, and growing demand for precision medicine. As the industry continues to evolve, it is essential for stakeholders to stay informed about the latest trends and developments in the Adults Genetic Disease Diagnosis market.

Report Overview

Report Attribute	Details
Market size value in 2025	7.80 billion
Revenue forecast in 2033	25.93 billion
Growth rate	CAGR of 16.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott; PerkinElmer; Roche Diagnostics; Bio-Rad; Thermo Fisher Scientific; BGI Group; Berry Genomics; Da An Gene Co.,Ltd.; Illumina; CapitalBio Technology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Adults Genetic Disease Diagnosis market is poised for significant growth, driven by advancements in genetic testing technologies and increasing awareness about genetic disorders. The growth forecast for this market is promising, with the Adults Genetic Disease Diagnosis market size expected to expand substantially over the next few years.

Growth Drivers2 items

Advances in next-generation sequencing technologies have improved the accuracy and speed of genetic disease diagnosis, leading to increased adoption of these tests among adults.

Government initiatives and awareness campaigns have contributed to the growing demand for genetic disease diagnosis, driving the Adults Genetic Disease Diagnosis market forward.

Restraints2 items

The high cost of genetic testing remains a significant barrier to adoption, particularly in developing economies where healthcare infrastructure and funding are limited.

The complexity of genetic data interpretation requires specialized expertise, which can be a constraint in areas with limited access to skilled healthcare professionals.

Opportunities2 items

The integration of artificial intelligence and machine learning in genetic disease diagnosis offers opportunities for improved accuracy and efficiency, enhancing the growth forecast of the Adults Genetic Disease Diagnosis market.

The increasing demand for personalized medicine has created new avenues for genetic disease diagnosis, enabling targeted treatments and therapies tailored to individual genetic profiles.

Challenges2 items

The Adults Genetic Disease Diagnosis market faces challenges related to data privacy and security, as the handling of sensitive genetic information requires stringent safeguards to prevent misuse.

The need for regulatory frameworks that keep pace with technological advancements in genetic testing is crucial, as outdated regulations can hinder innovation and growth in the Adults Genetic Disease Diagnosis market size.

Market Segmentation

Loading chart…

The Application segment in the Adults Genetic Disease Diagnosis market refers to the various uses of genetic disease diagnosis in adults. This segment is crucial in understanding the Adults Genetic Disease Diagnosis segmentation as it highlights the different areas where genetic disease diagnosis is applied, such as predictive testing, diagnostic testing, and carrier testing. The application segment contributes significantly to the overall market size, with predictive testing being the largest contributor.

The Types segment in the Adults Genetic Disease Diagnosis market is further divided into subtypes, including single-gene disorders, chromosomal disorders, and complex disorders. This segmentation is essential in understanding the market taxonomy, as it provides insights into the various types of genetic diseases diagnosed in adults. Single-gene disorders, such as sickle cell anemia and cystic fibrosis, account for a significant share of the market, while chromosomal disorders, such as Down syndrome, also contribute substantially to the overall market size.

Adults Genetic Disease Diagnosis Segmentation Breakdown9 items

Application

Hospital

Medical Laboratory

Others

Types

Prenatal Diagnosis

Screening for Single Gene Genetic Disease

Preimplantation Genetic Testing

Others

Regional Insights

Loading chart…

The Adults Genetic Disease Diagnosis market growth is anticipated to be driven by various factors across different regions. North America is the largest region, accounting for approximately 40% of the market share, driven by key drivers such as high adoption of genetic testing, favorable policies, and significant investments in research and development. Europe is the second-largest region, with a share of around 30%, driven by factors such as increasing demographics with genetic disorders, advanced infrastructure, and a mature ecosystem.

The Asia Pacific region is the fastest-growing region, with a projected regional forecast of 15% annual growth rate, driven by key drivers such as growing awareness of genetic diseases, increasing access to genetic testing, and rising demand for personalized medicine. Latin America and Middle East & Africa are also expected to contribute to the Adults Genetic Disease Diagnosis market growth, with shares of around 10% and 5%, respectively, driven by factors such as improving healthcare infrastructure, expanding genetic testing services, and increasing government initiatives.

Competitive Landscape

The Adults Genetic Disease Diagnosis market is moderately consolidated, with a mix of global players and local companies competing on various levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Adults Genetic Disease Diagnosis competitive landscape is characterized by high competition, with key players focusing on product differentiation and strategic partnerships to gain market share. Global players are expanding their presence through acquisitions and partnerships, while local companies are focusing on regional expansion and localization.

Companies in this market are adopting various strategies such as M&A, partnerships, product launches, and expansion to stay competitive. They are also focusing on competitive differentiation through technology, service model, channel strength, customization, and cost advantages. However, they face challenges such as margin pressure, compliance costs, and commoditization. To overcome these challenges, companies are investing in R&D, expanding their product portfolios, and strengthening their distribution networks.

Abbott: regional expansion

PerkinElmer: premium pricing

Roche Diagnostics: innovation pipeline

Thermo Fisher Scientific: OEM tie-ups

Illumina: vertical integration

BGI Group: local manufacturing

Key Adults Genetic Disease Diagnosis Companies10 items

Abbott

PerkinElmer

Roche Diagnostics

Bio-Rad

Thermo Fisher Scientific

BGI Group

Berry Genomics

Da An Gene Co.,Ltd.

Illumina

CapitalBio Technology

Market Ecosystem

The Adults Genetic Disease Diagnosis ecosystem encompasses a complex network of participants, spanning upstream technology providers to downstream end users. This ecosystem can be broadly segmented into three stages: upstream, where raw materials and components are sourced; midstream, where these inputs are integrated into diagnostic solutions; and downstream, where finished products are distributed to end users. Value is created and captured at each stage, with technology providers and suppliers influencing the development of diagnostic solutions, and end users ultimately driving demand.

Raw material/component suppliers — provide genetic testing materials

Technology providers — develop genetic diagnostic technologies

System integrators / EPCs — integrate diagnostic systems

Distributors / channel partners — distribute diagnostic products

Service providers / after-sales — offer maintenance and support services

End users / buyers — purchase and utilize diagnostic solutions

Regulators/standards bodies — establish diagnostic standards and approvals

In the Adults Genetic Disease Diagnosis ecosystem, control points are primarily held by regulators and standards bodies, who influence adoption through approvals and guidelines. Dependency risks arise from input constraints, such as the availability of genetic materials, and standards, which can vary by region. Switching costs and partnerships are also critical, as diagnostic solutions often require significant investment and collaboration between technology providers and end users. A thorough value chain analysis is necessary to understand these dynamics and how they impact the ecosystem, particularly in diverse regions with differing regulatory frameworks and market demands.

Recent Industry Insights

The Adults Genetic Disease Diagnosis industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as the collaboration between genetic testing companies and research institutions, have accelerated the discovery of new genetic markers and diagnostic techniques. Furthermore, mergers and acquisitions have led to the consolidation of key players, resulting in enhanced research and development capabilities.

Notable product launches include the introduction of next-generation sequencing technologies, enabling faster and more accurate diagnosis of genetic diseases. Regulatory changes, such as the updated guidelines for genetic testing, have also impacted the industry. Additionally, a shift in consumer trends towards personalized medicine has driven demand for genetic disease diagnosis, with several companies securing funding rounds to expand their offerings and improve accessibility.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Adults Genetic Disease Diagnosis market. The market attractiveness is high due to the increasing prevalence of genetic diseases and advancements in diagnostic technologies. The competitive intensity is moderate, with key players focusing on innovative solutions and strategic partnerships. The long-term outlook for the Adults Genetic Disease Diagnosis market outlook is positive, driven by growing demand for personalized medicine and targeted therapies. The innovation landscape is evolving, with emerging technologies such as next-generation sequencing and artificial intelligence transforming the diagnosis and treatment of genetic diseases.

The demand-supply balance is expected to be stable, with increasing demand for diagnostic services met by expanding capacities and new market entrants. Key risk factors include regulatory changes and reimbursement pressures, which may impact market growth. Overall, the Adults Genetic Disease Diagnosis market is poised for significant growth, driven by advances in technology, increasing awareness, and growing demand for genetic disease diagnosis and treatment.

11 items

1. Executive Summary

2. Adults Genetic Disease Diagnosis Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Adults Genetic Disease Diagnosis Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Adults Genetic Disease Diagnosis Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Medical Laboratory

6.1.3. Others

6.2. Global Adults Genetic Disease Diagnosis Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Prenatal Diagnosis

6.2.2. Screening for Single Gene Genetic Disease

6.2.3. Preimplantation Genetic Testing

6.2.4. Others

6.3. Global Adults Genetic Disease Diagnosis Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Adults Genetic Disease Diagnosis Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Adults Genetic Disease Diagnosis Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Adults Genetic Disease Diagnosis Market Competition by Key Manufacturers

8.1. Global Adults Genetic Disease Diagnosis Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Adults Genetic Disease Diagnosis: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Abbott

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. PerkinElmer

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Roche Diagnostics

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Bio-Rad

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Thermo Fisher Scientific

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. BGI Group

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Berry Genomics

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Da An Gene Co.,Ltd.

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Illumina

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. CapitalBio Technology

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Adults Genetic Disease Diagnosis Market

Figure 4: Global Adults Genetic Disease Diagnosis Market: Drivers

Figure 5: Global Adults Genetic Disease Diagnosis Market: Challenges

Figure 6: Global Adults Genetic Disease Diagnosis Market: Trends

Figure 7: Global Adults Genetic Disease Diagnosis Market: Opportunity

Figure 8: Global Adults Genetic Disease Diagnosis Market: Restraint

Figure 9: Global Adults Genetic Disease Diagnosis Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Adults Genetic Disease Diagnosis Market Value (USD Million) By Region

Figure 15: Global Adults Genetic Disease Diagnosis Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Adults Genetic Disease Diagnosis Market Value (USD Million) By Region

Figure 23: Global Adults Genetic Disease Diagnosis Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global Adults Genetic Disease Diagnosis Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Adults Genetic Disease Diagnosis Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Adults Genetic Disease Diagnosis Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Adults Genetic Disease Diagnosis Market Value (USD Million) By Region

Table 10: Global Adults Genetic Disease Diagnosis Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Adults Genetic Disease Diagnosis Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Adults Genetic Disease Diagnosis Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Adults Genetic Disease Diagnosis Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Abbott Basic Information And Sales Area

Table 31: Abbott. Products Portfolio

Table 32: PerkinElmer Basic Information And Sales Area

Table 33: PerkinElmer. Products Portfolio

Table 34: Roche Diagnostics Basic Information And Sales Area

Table 35: Roche Diagnostics. Products Portfolio

Table 36: Bio-Rad Basic Information And Sales Area

Table 37: Bio-Rad. Products Portfolio

Table 38: Thermo Fisher Scientific Basic Information And Sales Area

Table 39: Thermo Fisher Scientific. Products Portfolio

Table 40: BGI Group Basic Information And Sales Area

Table 41: BGI Group. Products Portfolio

Table 42: Berry Genomics Basic Information And Sales Area

Table 43: Berry Genomics. Products Portfolio

Table 44: Da An Gene Co.,Ltd. Basic Information And Sales Area

Table 45: Da An Gene Co.,Ltd.. Products Portfolio

Table 46: Illumina Basic Information And Sales Area

Table 47: Illumina. Products Portfolio

Table 48: CapitalBio Technology Basic Information And Sales Area

Table 49: CapitalBio Technology. Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Application

Table 51: Global Market Share (%) By Application (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Types

Table 53: Global Market Share (%) By Types (2032)

Table 54: Global Adults Genetic Disease Diagnosis Market Value (USD Million) By Region

Table 55: Global Adults Genetic Disease Diagnosis Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Application

Table 58: North America Market Value (USD Million) (2025-2032) By Types

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Application

Table 61: Europe Market Value (USD Million) (2025-2032) By Types

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Application

Table 67: South America Market Value (USD Million) (2025-2032) By Types

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Adults Genetic Disease Diagnosis Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	7.80 billion
Revenue forecast in 2033	25.93 billion
Growth rate	CAGR of 16.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott; PerkinElmer; Roche Diagnostics; Bio-Rad; Thermo Fisher Scientific; BGI Group; Berry Genomics; Da An Gene Co.,Ltd.; Illumina; CapitalBio Technology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options